Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Verrica Pharmaceuticals Inc. Common Stock

VRCA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of VRCA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
VRCA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
VRCA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
VRCA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in VRCA holdings by institutional investors

Quarterly net insider trading by VRCA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for VRCA

Quiver Logo

No former government officials on record as having lobbied for VRCA

Revolving Door Dashboard

VRCA Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

VRCA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
VRCA Income Statement
VRCA Balance Sheet
VRCA Cash Flow
U.S. Patents

New VRCA patent grants

  • Patent Title: Devices and methods for the treatment of body surface disorders May. 06, 2025
  • Patent Title: Treatment of cutaneous disorders Feb. 25, 2025
  • Patent Title: Synthesis of cantharidin Feb. 11, 2025
  • Patent Title: Applicator Jul. 23, 2024
  • Patent Title: Ampule crush tool Apr. 11, 2023
  • Patent Title: Quantification and preparation of pharmaceutical grade cantharidin Nov. 09, 2021
  • Patent Title: Treatment of cutaneous disorders Oct. 19, 2021
  • Patent Title: Compositions, methods and systems for the treatment of cutaneous disorders Jul. 06, 2021
  • Patent Title: Applicator Oct. 27, 2020
  • Patent Title: Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives Aug. 18, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to VRCA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
VRCA News

Recent insights relating to VRCA

CNBC Recommendations

Recent picks made for VRCA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VRCA

VRCA Analyst Ratings

VRCA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
VRCA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $VRCA stock a Buy, Sell, or Hold?

  • What is the price target for $VRCA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

VRCA Top Shareholders
Shareholder
Shares Held
VRCA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $VRCA stock?

  • Who owns the most shares of $VRCA stock?

  • What funds own $VRCA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

VRCA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view VRCA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About VRCA

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

  • Address West Chester, PA
  • Market Cap 74.9 million
  • Employees 76
  • Industrial Classification Pharmaceutical Preparations

Verrica Pharmaceuticals Inc. Common Stock (VRCA) Historical Stock Prices

Verrica Pharmaceuticals Inc. Common Stock (VRCA) closed at $4.36 on September 24, 2026. Over the past year its adjusted close ranged from $3.28 to $9.10. Daily prices go back to June 15, 2018, 2,080 trading days in all.

  • 1 month-11.74%
  • 3 months-29.79%
  • Year to date-47.53%
  • 1 year+4.56%
  • 3 years-88.85%
  • 5 years-96.21%
  • Max-97.51%
See every congressional and insider trade on the VRCA price chart

Quiver Premium charts VRCA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 4.62 4.64 4.36 4.36 4.36 40,899
Sep 23, 2026 4.67 4.78 4.55 4.62 4.62 41,334
Sep 22, 2026 4.50 4.90 4.50 4.72 4.72 65,141
Sep 21, 2026 4.55 4.63 4.40 4.49 4.49 29,589
Sep 18, 2026 4.61 4.74 4.45 4.45 4.45 114,163
Sep 17, 2026 4.70 4.79 4.57 4.65 4.65 41,344
Sep 16, 2026 4.66 4.70 4.53 4.53 4.53 48,296
Sep 15, 2026 4.75 4.77 4.51 4.58 4.58 46,439
Sep 14, 2026 4.91 5.06 4.70 4.78 4.78 43,103
Sep 11, 2026 4.99 5.03 4.80 4.91 4.91 41,892
Sep 10, 2026 5.06 5.25 4.86 4.95 4.95 56,966
Sep 9, 2026 5.25 5.40 5.05 5.06 5.06 47,809
Sep 8, 2026 5.30 5.41 5.04 5.26 5.26 112,198
Sep 4, 2026 5.28 5.53 5.25 5.30 5.30 12,197
Sep 3, 2026 5.48 5.63 5.27 5.36 5.36 55,385
Sep 2, 2026 5.32 5.56 5.28 5.39 5.39 31,077
Sep 1, 2026 5.36 5.56 5.22 5.24 5.24 43,490
Aug 31, 2026 5.70 5.83 5.29 5.46 5.46 106,418
Aug 28, 2026 5.12 5.86 5.00 5.69 5.69 351,919
Aug 27, 2026 5.01 5.65 4.90 5.07 5.07 533,709
Aug 26, 2026 4.86 5.05 4.84 4.91 4.91 27,663
Aug 25, 2026 4.90 4.99 4.75 4.94 4.94 54,908
Aug 24, 2026 4.81 4.95 4.61 4.87 4.87 67,960
Aug 21, 2026 4.90 4.99 4.64 4.82 4.82 78,823
Aug 20, 2026 4.99 5.18 4.83 4.86 4.86 138,482
Aug 19, 2026 5.22 5.22 4.77 4.99 4.99 169,810
Aug 18, 2026 4.90 5.00 4.68 4.68 4.68 50,296
Aug 17, 2026 5.00 5.15 4.77 4.89 4.89 179,717
Aug 14, 2026 4.89 5.10 4.78 4.97 4.97 59,636
Aug 13, 2026 5.11 5.35 4.77 4.86 4.86 56,335
Aug 12, 2026 5.19 5.25 5.05 5.09 5.09 26,920
Aug 11, 2026 5.21 5.85 5.12 5.22 5.22 82,246
Aug 10, 2026 5.18 5.34 5.06 5.12 5.12 22,271
Aug 7, 2026 5.31 5.50 4.70 5.08 5.08 126,327
Aug 6, 2026 5.58 5.87 5.26 5.36 5.36 85,193
Aug 5, 2026 5.48 5.61 5.41 5.51 5.51 12,009
Aug 4, 2026 5.23 5.51 5.20 5.41 5.41 28,449
Aug 3, 2026 5.22 5.54 5.08 5.25 5.25 32,363
Jul 31, 2026 5.27 5.55 5.21 5.22 5.22 5,043
Jul 30, 2026 5.17 5.39 5.17 5.26 5.26 7,016
Jul 29, 2026 5.35 5.79 5.00 5.18 5.18 30,911
Jul 28, 2026 5.38 5.87 5.38 5.40 5.40 48,817
Jul 27, 2026 5.08 5.44 5.00 5.35 5.35 102,111
Jul 24, 2026 5.46 5.46 5.02 5.02 5.02 16,746
Jul 23, 2026 5.60 5.68 5.44 5.44 5.44 17,371
Jul 22, 2026 5.49 5.74 5.41 5.70 5.70 36,692
Jul 21, 2026 5.41 5.64 5.39 5.44 5.44 11,853
Jul 20, 2026 5.60 5.85 5.49 5.49 5.49 6,614
Jul 17, 2026 5.44 5.65 5.12 5.59 5.59 48,994
Jul 16, 2026 5.60 5.98 5.50 5.56 5.56 23,632
Jul 15, 2026 5.93 6.01 5.65 5.66 5.66 30,884
Jul 14, 2026 5.93 6.09 5.82 5.93 5.93 10,657
Jul 13, 2026 6.19 6.39 5.92 5.92 5.92 13,819
Jul 10, 2026 6.57 6.57 6.26 6.26 6.26 14,050
Jul 9, 2026 6.49 6.63 6.11 6.53 6.53 35,256
Jul 8, 2026 6.01 6.79 6.01 6.62 6.62 75,202
Jul 7, 2026 6.02 6.37 6.02 6.07 6.07 10,756
Jul 6, 2026 6.07 6.60 5.90 6.13 6.13 40,367
Jul 2, 2026 5.95 6.18 5.95 6.13 6.13 22,949
Jul 1, 2026 6.13 6.20 5.72 5.94 5.94 35,424
Jun 30, 2026 6.47 6.47 6.09 6.12 6.12 34,497
Jun 29, 2026 6.74 6.93 6.23 6.50 6.50 66,683
Jun 26, 2026 6.11 7.00 6.10 6.84 6.84 113,864
Jun 25, 2026 5.96 6.54 5.86 6.21 6.21 62,472
Jun 24, 2026 5.66 6.12 5.66 5.85 5.85 24,149
Jun 23, 2026 5.46 5.92 5.30 5.65 5.65 34,302
Jun 22, 2026 5.63 6.19 5.63 5.64 5.64 105,088
Jun 18, 2026 5.85 5.87 5.62 5.63 5.63 26,785
Jun 17, 2026 5.98 6.11 5.83 5.83 5.83 12,418
Jun 16, 2026 5.83 6.13 5.67 6.00 6.00 43,201
Jun 15, 2026 5.80 6.20 5.79 5.81 5.81 31,117
Jun 12, 2026 6.06 6.20 5.70 5.73 5.73 49,862
Jun 11, 2026 5.83 6.22 5.60 6.03 6.03 38,224
Jun 10, 2026 5.91 6.48 5.74 5.75 5.75 51,974
Jun 9, 2026 6.03 6.38 5.94 6.12 6.12 33,040
Jun 8, 2026 6.05 6.34 5.87 5.99 5.99 37,708
Jun 5, 2026 6.30 6.80 6.00 6.04 6.04 60,525
Jun 4, 2026 5.89 6.38 5.86 6.15 6.15 43,035
Jun 3, 2026 5.85 6.07 5.62 5.87 5.87 24,840
Jun 2, 2026 5.85 6.17 5.79 5.79 5.79 28,733
Jun 1, 2026 5.87 6.10 5.66 5.90 5.90 24,012
May 29, 2026 5.86 6.11 5.75 5.76 5.76 35,663
May 28, 2026 6.07 6.38 6.00 6.04 6.04 45,341
May 27, 2026 6.09 6.49 5.93 6.06 6.06 25,888
May 26, 2026 6.30 6.30 6.01 6.02 6.02 25,534
May 22, 2026 5.92 6.25 5.48 6.06 6.06 71,896
May 21, 2026 5.91 6.15 5.71 5.90 5.90 35,398
May 20, 2026 5.63 6.17 5.57 6.02 6.02 31,341
May 19, 2026 5.87 5.99 5.56 5.59 5.59 50,312
May 18, 2026 6.27 6.42 5.87 5.87 5.87 50,055
May 15, 2026 6.85 6.90 6.21 6.27 6.27 81,594
May 14, 2026 7.48 7.59 6.80 6.95 6.95 82,234
May 13, 2026 6.91 8.20 6.81 7.37 7.37 248,701
May 12, 2026 7.37 7.42 6.88 7.15 7.15 36,617
May 11, 2026 7.85 7.85 7.40 7.40 7.40 42,887
May 8, 2026 8.19 8.23 7.72 7.99 7.99 110,370
May 7, 2026 8.32 8.34 7.67 8.24 8.24 102,943
May 6, 2026 7.14 8.50 6.95 8.43 8.43 475,389
May 5, 2026 6.43 7.20 6.38 7.16 7.16 59,229
May 4, 2026 6.19 6.59 6.19 6.36 6.36 39,719
May 1, 2026 6.39 6.58 6.15 6.27 6.27 25,399
Apr 30, 2026 6.67 6.71 6.37 6.37 6.37 27,001
Apr 29, 2026 6.50 6.75 6.29 6.58 6.58 112,390
Apr 28, 2026 6.75 6.96 6.50 6.53 6.53 21,773
Apr 27, 2026 6.90 7.29 6.75 6.83 6.83 117,377
Apr 24, 2026 6.55 7.03 6.38 6.98 6.98 112,697
Apr 23, 2026 6.39 6.69 6.38 6.49 6.49 81,724
Apr 22, 2026 6.45 6.57 6.33 6.50 6.50 19,921
Apr 21, 2026 6.40 6.60 6.25 6.32 6.32 75,244
Apr 20, 2026 6.30 6.76 6.17 6.38 6.38 74,553
Apr 17, 2026 6.32 6.60 6.20 6.32 6.32 109,861
Apr 16, 2026 6.00 6.45 5.67 6.21 6.21 153,888
Apr 15, 2026 5.75 5.96 5.64 5.91 5.91 59,978
Apr 14, 2026 5.70 6.00 5.66 5.72 5.72 134,793
Apr 13, 2026 5.11 5.71 5.11 5.62 5.62 87,869
Apr 10, 2026 5.81 5.81 5.10 5.11 5.11 169,191
Apr 9, 2026 5.82 5.91 5.57 5.83 5.83 20,803
Apr 8, 2026 5.96 6.15 5.82 5.82 5.82 119,024
Apr 7, 2026 5.95 5.95 5.71 5.82 5.82 44,572
Apr 6, 2026 5.50 6.01 5.50 5.98 5.98 75,392
Apr 2, 2026 5.36 5.49 5.21 5.47 5.47 38,647
Apr 1, 2026 5.31 5.60 4.99 5.49 5.49 129,608
Mar 31, 2026 4.83 5.30 4.53 5.29 5.29 67,045
Mar 30, 2026 4.43 4.87 4.43 4.76 4.76 68,919
Mar 27, 2026 4.37 4.62 4.31 4.38 4.38 66,858
Mar 26, 2026 4.49 4.64 4.33 4.39 4.39 94,009
Mar 25, 2026 4.48 4.76 4.47 4.62 4.62 65,313
Mar 24, 2026 4.82 5.20 4.25 4.48 4.48 141,305
Mar 23, 2026 5.66 5.66 4.80 4.85 4.85 141,146
Mar 20, 2026 5.76 5.96 5.35 5.45 5.45 401,501
Mar 19, 2026 5.53 5.96 5.51 5.80 5.80 127,307
Mar 18, 2026 6.24 6.38 5.71 5.71 5.71 113,853
Mar 17, 2026 6.14 6.53 6.07 6.31 6.31 94,978
Mar 16, 2026 6.07 6.20 5.80 6.17 6.17 151,420
Mar 13, 2026 6.13 6.34 5.96 6.11 6.11 87,818
Mar 12, 2026 6.16 6.56 5.93 6.15 6.15 171,048
Mar 11, 2026 5.05 6.51 5.05 6.26 6.26 222,035
Mar 10, 2026 5.71 6.08 5.37 5.98 5.98 272,035
Mar 9, 2026 5.27 6.11 5.27 5.68 5.68 236,846
Mar 6, 2026 5.10 5.35 5.09 5.31 5.31 71,433
Mar 5, 2026 5.21 5.39 5.06 5.20 5.20 58,855
Mar 4, 2026 5.15 5.50 5.13 5.33 5.33 110,483
Mar 3, 2026 5.20 5.34 5.00 5.12 5.12 179,090
Mar 2, 2026 5.31 5.68 5.20 5.37 5.37 134,188
Feb 27, 2026 5.42 5.58 5.35 5.47 5.47 66,962
Feb 26, 2026 5.58 5.70 5.44 5.47 5.47 92,904
Feb 25, 2026 5.59 5.75 5.57 5.57 5.57 37,816
Feb 24, 2026 5.60 5.92 5.50 5.59 5.59 86,335
Feb 23, 2026 5.77 5.79 5.38 5.61 5.61 67,762
Feb 20, 2026 6.20 6.38 5.67 5.79 5.79 71,472
Feb 19, 2026 6.02 6.37 6.00 6.30 6.30 74,952
Feb 18, 2026 5.54 6.26 5.38 6.07 6.07 371,645
Feb 17, 2026 5.66 5.84 5.45 5.51 5.51 146,038
Feb 13, 2026 5.61 5.97 5.61 5.69 5.69 144,855
Feb 12, 2026 5.60 5.79 5.41 5.56 5.56 139,497
Feb 11, 2026 6.09 6.09 5.67 5.69 5.69 156,509
Feb 10, 2026 6.87 7.10 6.02 6.03 6.03 215,212
Feb 9, 2026 6.92 7.15 6.71 6.91 6.91 116,038
Feb 6, 2026 6.70 7.07 6.70 6.91 6.91 124,245
Feb 5, 2026 7.02 7.15 6.52 6.61 6.61 245,345
Feb 4, 2026 7.38 7.41 7.00 7.14 7.14 113,090
Feb 3, 2026 7.52 7.56 7.04 7.39 7.39 128,814
Feb 2, 2026 7.40 7.84 7.25 7.45 7.45 257,902
Jan 30, 2026 7.08 7.29 7.00 7.03 7.03 127,605
Jan 29, 2026 7.20 7.34 7.05 7.21 7.21 77,251
Jan 28, 2026 7.33 7.45 7.18 7.18 7.18 52,921
Jan 27, 2026 7.38 7.46 7.25 7.31 7.31 40,237
Jan 26, 2026 7.45 7.51 7.24 7.39 7.39 75,322
Jan 23, 2026 7.77 7.89 7.38 7.42 7.42 72,112
Jan 22, 2026 7.76 8.01 7.65 7.73 7.73 36,220
Jan 21, 2026 7.93 8.24 7.74 7.76 7.76 105,044
Jan 20, 2026 7.14 8.03 7.07 7.94 7.94 393,038
Jan 16, 2026 7.58 7.61 7.21 7.26 7.26 393,577
Jan 15, 2026 7.98 8.20 7.50 7.61 7.61 275,894
Jan 14, 2026 8.00 8.07 7.85 7.95 7.95 79,997
Jan 13, 2026 8.02 8.20 7.93 8.02 8.02 204,328
Jan 12, 2026 7.99 8.27 7.79 8.02 8.02 150,756
Jan 9, 2026 8.13 8.15 7.83 7.95 7.95 158,011
Jan 8, 2026 8.11 8.30 7.92 8.02 8.02 111,296
Jan 7, 2026 8.03 8.30 7.94 8.12 8.12 189,985
Jan 6, 2026 8.87 8.93 7.90 8.05 8.05 199,219
Jan 5, 2026 8.40 8.95 8.13 8.87 8.87 168,041
Jan 2, 2026 8.48 8.52 8.05 8.30 8.30 71,164
Dec 31, 2025 8.22 8.70 8.08 8.31 8.31 154,159
Dec 30, 2025 8.18 9.02 7.60 8.30 8.30 462,301
Dec 29, 2025 7.99 8.38 7.65 8.20 8.20 159,026
Dec 26, 2025 8.39 8.48 7.95 8.16 8.16 129,134
Dec 24, 2025 8.17 8.68 8.00 8.33 8.33 121,784
Dec 23, 2025 7.86 8.50 7.75 8.21 8.21 180,093
Dec 22, 2025 7.86 8.32 7.81 7.91 7.91 99,757
Dec 19, 2025 8.13 8.52 7.80 7.82 7.82 266,660
Dec 18, 2025 8.69 9.03 8.00 8.11 8.11 287,025
Dec 17, 2025 8.73 8.99 7.84 8.05 8.05 231,555
Dec 16, 2025 7.42 8.92 7.23 8.60 8.60 285,512
Dec 15, 2025 7.95 8.30 7.06 7.56 7.56 282,681
Dec 12, 2025 8.41 8.60 7.88 7.92 7.92 170,594
Dec 11, 2025 8.27 8.60 7.88 8.30 8.30 207,354
Dec 10, 2025 8.33 8.49 7.82 8.24 8.24 135,486
Dec 9, 2025 8.14 8.91 8.05 8.27 8.27 182,563
Dec 8, 2025 8.82 9.50 7.90 8.11 8.11 182,588
Dec 5, 2025 8.40 9.78 7.80 8.81 8.81 318,024
Dec 4, 2025 7.43 8.47 7.20 8.42 8.42 195,329
Dec 3, 2025 6.68 7.60 6.57 7.48 7.48 179,096
Dec 2, 2025 7.29 7.50 6.26 6.73 6.73 361,695
Dec 1, 2025 7.99 8.18 7.30 7.55 7.55 851,623
Nov 28, 2025 7.30 9.82 6.92 9.10 9.10 2,621,454
Nov 26, 2025 5.56 6.79 5.50 6.71 6.71 1,155,147
Nov 25, 2025 4.81 5.32 4.73 5.12 5.12 269,600
Nov 24, 2025 4.41 5.18 4.40 4.72 4.72 581,878
Nov 21, 2025 4.09 4.26 3.90 4.21 4.21 53,249
Nov 20, 2025 4.47 4.64 3.90 4.02 4.02 116,116
Nov 19, 2025 3.85 4.55 3.85 4.48 4.48 275,478
Nov 18, 2025 3.87 3.94 3.64 3.83 3.83 83,823
Nov 17, 2025 3.84 3.99 3.71 3.73 3.73 126,506
Nov 14, 2025 3.79 4.01 3.73 3.93 3.93 51,376
Nov 13, 2025 3.83 4.00 3.68 3.87 3.87 109,963
Nov 12, 2025 3.70 3.90 3.62 3.82 3.82 49,577
Nov 11, 2025 3.87 3.87 3.62 3.66 3.66 41,368
Nov 10, 2025 3.55 3.99 3.55 3.87 3.87 117,470
Nov 7, 2025 3.51 3.51 3.36 3.46 3.46 72,077
Nov 6, 2025 3.44 3.73 3.42 3.58 3.58 48,749
Nov 5, 2025 3.44 3.55 3.35 3.45 3.45 58,600
Nov 4, 2025 3.47 3.57 3.28 3.28 3.28 70,891
Nov 3, 2025 3.70 3.81 3.51 3.56 3.56 48,088
Oct 31, 2025 3.49 3.68 3.47 3.61 3.61 33,095
Oct 30, 2025 3.63 3.63 3.43 3.53 3.53 44,738
Oct 29, 2025 3.70 3.79 3.51 3.61 3.61 94,728
Oct 28, 2025 3.77 3.77 3.60 3.62 3.62 142,912
Oct 27, 2025 3.85 3.96 3.73 3.76 3.76 109,093
Oct 24, 2025 3.95 3.95 3.78 3.85 3.85 80,507
Oct 23, 2025 3.90 4.10 3.73 3.95 3.95 221,363
Oct 22, 2025 4.03 4.04 3.80 3.91 3.91 195,482
Oct 21, 2025 3.99 4.19 3.85 4.04 4.04 658,193
Oct 20, 2025 4.17 4.54 4.13 4.48 4.48 2,670,803
Oct 17, 2025 4.21 4.23 3.95 4.15 4.15 68,841
Oct 16, 2025 4.14 4.35 3.93 4.23 4.23 140,673
Oct 15, 2025 4.05 4.15 3.96 4.10 4.10 58,213
Oct 14, 2025 4.09 4.15 3.95 4.11 4.11 66,028
Oct 13, 2025 4.15 4.26 3.96 4.10 4.10 73,069
Oct 10, 2025 4.27 4.36 4.10 4.14 4.14 115,616
Oct 9, 2025 4.37 4.85 4.09 4.30 4.30 191,153
Oct 8, 2025 4.40 4.58 4.26 4.42 4.42 268,847
Oct 7, 2025 4.66 4.73 4.46 4.61 4.61 2,206,471
Oct 6, 2025 4.75 4.75 4.47 4.69 4.69 58,596
Oct 3, 2025 4.56 4.72 4.47 4.67 4.67 57,454
Oct 2, 2025 4.50 4.55 4.31 4.54 4.54 65,043
Oct 1, 2025 4.33 4.49 4.24 4.44 4.44 47,313
Sep 30, 2025 4.29 4.36 4.17 4.31 4.31 20,471
Sep 29, 2025 4.26 4.39 4.21 4.30 4.30 58,103
Sep 26, 2025 4.06 4.31 4.00 4.18 4.18 42,917
Sep 25, 2025 4.15 4.40 4.01 4.09 4.09 61,058
Sep 24, 2025 4.33 4.33 4.00 4.17 4.17 154,882

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Verrica Pharmaceuticals Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at VRCA, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation